244 related articles for article (PubMed ID: 37532939)
1. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP.
Arseni D; Chen R; Murzin AG; Peak-Chew SY; Garringer HJ; Newell KL; Kametani F; Robinson AC; Vidal R; Ghetti B; Hasegawa M; Ryskeldi-Falcon B
Nature; 2023 Aug; 620(7975):898-903. PubMed ID: 37532939
[TBL] [Abstract][Full Text] [Related]
2. Structure of pathological TDP-43 filaments from ALS with FTLD.
Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
[TBL] [Abstract][Full Text] [Related]
3. TAF15 amyloid filaments in frontotemporal lobar degeneration.
Tetter S; Arseni D; Murzin AG; Buhidma Y; Peak-Chew SY; Garringer HJ; Newell KL; Vidal R; Apostolova LG; Lashley T; Ghetti B; Ryskeldi-Falcon B
Nature; 2024 Jan; 625(7994):345-351. PubMed ID: 38057661
[TBL] [Abstract][Full Text] [Related]
4. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
[TBL] [Abstract][Full Text] [Related]
5. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
6. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.
Jiang YX; Cao Q; Sawaya MR; Abskharon R; Ge P; DeTure M; Dickson DW; Fu JY; Ogorzalek Loo RR; Loo JA; Eisenberg DS
Nature; 2022 May; 605(7909):304-309. PubMed ID: 35344984
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing post-translational modifications in dominantly inherited frontotemporal dementias: FTLD-TDP Type A (GRN) vs Type B (C9orf72).
Cracco L; Doud EH; Hallinan GI; Garringer HJ; Jacobsen MH; Richardson RM; Buratti E; Vidal R; Ghetti B; Newell KL
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12836. PubMed ID: 35836354
[TBL] [Abstract][Full Text] [Related]
8. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.
Janssens J; Van Broeckhoven C
Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071
[TBL] [Abstract][Full Text] [Related]
9. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
10. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
Tamaki Y; Urushitani M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
[TBL] [Abstract][Full Text] [Related]
13. [FTLD/ALS as TDP-43 proteinopathies].
Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
Carlos AF; Josephs KA
J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398
[TBL] [Abstract][Full Text] [Related]
15. Towards a TDP-43-Based Biomarker for ALS and FTLD.
Feneberg E; Gray E; Ansorge O; Talbot K; Turner MR
Mol Neurobiol; 2018 Oct; 55(10):7789-7801. PubMed ID: 29460270
[TBL] [Abstract][Full Text] [Related]
16. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 variants of frontotemporal lobar degeneration.
Bigio EH
J Mol Neurosci; 2011 Nov; 45(3):390-401. PubMed ID: 21607722
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
Geser F; Lee VM; Trojanowski JQ
Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
